Huda Zoghbi is a Howard Hughes Medical Institute investigator and professor of molecular and human genetics at Baylor College of Medicine in Houston, Texas. She is also director of the Jan and Dan Duncan Neurological Research Institute. Zoghbi explores the biology of genetic disorders such as Rett syndrome, and the genes essential for normal neurodevelopment.
Huda Zoghbi
Professor
Baylor College of Medicine
From this contributor
Remembering Steve Warren (1953-2021): A giant in the field of genetics
Steve Warren co-discovered the genetic mechanism that underpins fragile X syndrome and was a generous, inspiring mentor to many.
Remembering Steve Warren (1953-2021): A giant in the field of genetics
By
Joseph Cubells, Evan Eichler, James Sutcliffe, Huda Zoghbi
6 September 2021 | 11 min read
Questions for Huda Zoghbi: Studying Rett in the rodent brain
Removing the Rett syndrome gene, MeCP2, from distinct cells and brain regions reveals hidden features of the condition.
Questions for Huda Zoghbi: Studying Rett in the rodent brain
By
Jessica Wright
14 March 2017 | 6 min read
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
By
Ashley Juavinett
30 March 2026 | 8 min read
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
By
Dalmeet Singh Chawla
27 March 2026 | 5 min read
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
By
Claudia López Lloreda
26 March 2026 | 4 min read